|
WO9926958A1
|
|
Nucleoside analog compositions and uses thereof
|
|
US5977174A
|
|
Cholinergic compositions and uses thereof
|
|
US5955459A
|
|
Fatty acid-antipsychotic compositions and uses thereof
|
|
WO9744026A1
|
|
Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
|
|
US5795909A
|
|
DHA-pharmaceutical agent conjugates of taxanes
|
|
US5919815A
|
|
Taxane compounds and compositions
|
|
US6107499A
|
|
Dopamine analog amide
|
|
US5994392A
|
|
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
|
US5545719A
|
|
Nerve growth peptides
|
|
US5284876A
|
|
Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
|
